Cargando…
A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice
Dengue viruses (DENV) cause an estimated 390 million infections globally. With no dengue-specific therapeutic treatment currently available, vaccination is the most promising strategy for its control. A wide range of DENV vaccines are in development, with one having already been licensed, albeit wit...
Autores principales: | Choo, Jovin J. Y., Vet, Laura J., McMillan, Christopher L. D., Harrison, Jessica J., Scott, Connor A. P., Depelsenaire, Alexandra C. I., Fernando, Germain J. P., Watterson, Daniel, Hall, Roy A., Young, Paul R., Hobson-Peters, Jody, Muller, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105366/ https://www.ncbi.nlm.nih.gov/pubmed/33963191 http://dx.doi.org/10.1038/s41541-021-00328-1 |
Ejemplares similares
-
Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch
por: Choo, Jovin J. Y., et al.
Publicado: (2021) -
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
por: McMillan, Christopher L. D., et al.
Publicado: (2021) -
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022) -
Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial
por: Depelsenaire, Alexandra C. I., et al.
Publicado: (2021) -
Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice
por: Scott, Connor A. P., et al.
Publicado: (2021)